Telix is a global, commercial-stage biopharmaceutical company focused on the development of diagnostic and therapeutic ('theranostic') products using targeted radiation. Our products use targeted radiation to image disease and deliver truly personalized therapy in areas of significant unmet medical needs. Telix's theranostic pipeline aims to address significant unmet medical needs in prostate, kidney, brain, and blood cancers, and a range of rare diseases.